One in five patients with rapidly and persistently controlled early rheumatoid arthritis report poor well-being after 1 year of treatment.
Kristien Van der ElstPatrick VerschuerenDiederik De CockAn De GroefVeerle StoutenSofia PazminoJohanna VriezekolkJohan JolyPhilip MoonsRené WesthovensPublished in: RMD open (2021)
Although most patients reported PRO scores in concordance with their well-controlled disease activity, one in five persistent treatment responders reported not feeling well at year 1. These patients reported higher pain and fatigue, and different illness perceptions and coping strategies early in the disease course.
Keyphrases
- rheumatoid arthritis
- disease activity
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- systemic lupus erythematosus
- ejection fraction
- peritoneal dialysis
- ankylosing spondylitis
- prognostic factors
- chronic pain
- depressive symptoms
- patient reported outcomes
- pain management
- spinal cord
- social support
- neuropathic pain
- physical activity
- combination therapy
- idiopathic pulmonary fibrosis
- systemic sclerosis